Gerresheimer AG Logo

Gerresheimer AG

Global provider of packaging and drug delivery systems for pharma, biotech, and cosmetics.

GXI | F

Overview

Corporate Details

ISIN(s):
DE000A0LD6E6
LEI:
5299006GD4UWSYZOKC28
Country:
Germany
Address:
Klaus-Bungert-Straße 4, 40468 Düsseldorf
Sector:
Manufacturing
Industry:
Manufacture of medical and dental instruments and supplies

Description

Gerresheimer AG is a global partner and solutions provider specializing in primary packaging and drug delivery systems for the pharmaceutical, biotech, and cosmetics industries. The company develops and manufactures a broad portfolio of high-quality glass and plastic products, including pharmaceutical vials, syringes, ampoules, cartridges, and containers. It also offers integrated solutions for drug delivery devices, such as inhalers and auto-injectors, acting as a full-service partner from concept development to the finished product. Additionally, Gerresheimer provides packaging for the perfume and personal care sectors and serves as a supplier for diagnostic and medical device components.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-10 00:00
Quarterly Report
Q3 statement / Q3 financial report 2024/2025
English 338.4 KB
2025-10-09 23:58
Earnings Release
Gerresheimer: Business performance and slower market growth require guidance ad…
English 16.0 KB
2025-10-09 10:29
Declaration of Voting Results & Voting Rights Announcements
English 19.1 KB
2025-10-08 22:09
Earnings Release
Gerresheimer AG: Business performance and slower market growth require adjustme…
English 8.1 KB
2025-10-07 11:24
Declaration of Voting Results & Voting Rights Announcements
English 14.7 KB
2025-10-06 09:48
Declaration of Voting Results & Voting Rights Announcements
English 19.1 KB
2025-10-01 13:04
Declaration of Voting Results & Voting Rights Announcements
English 15.8 KB
2025-09-26 09:31
Declaration of Voting Results & Voting Rights Announcements
English 16.2 KB
2025-09-24 10:48
Legal Proceedings Report
Gerresheimer comments on the audit by German BaFin
English 7.5 KB
2025-09-18 09:16
Declaration of Voting Results & Voting Rights Announcements
English 14.9 KB
2025-09-17 08:25
Declaration of Voting Results & Voting Rights Announcements
English 19.4 KB
2025-09-15 11:07
Declaration of Voting Results & Voting Rights Announcements
English 15.8 KB
2025-09-10 21:26
Declaration of Voting Results & Voting Rights Announcements
English 15.8 KB
2025-09-08 23:44
Declaration of Voting Results & Voting Rights Announcements
English 19.4 KB
2025-09-03 23:56
Declaration of Voting Results & Voting Rights Announcements
English 19.4 KB

Automate Your Workflow. Get a real-time feed of all Gerresheimer AG filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Gerresheimer AG via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2024-11-13 Siemssen, Dietmar Board Buy None 74,994.10 EUR
2022-10-14 Siemssen, Dietmar Board Buy None 137,500.00 EUR
2022-10-14 Simon-Schröter, Dr Wolfram Other Buy None 2,958.00 EUR
2022-09-19 Abt, Andrea Supervisory board Buy None 25,075.00 EUR
2022-09-19 Empl, Andreas Board Buy None 1,820.00 EUR
2022-07-18 Siemssen, Dietmar Board Buy None 151,730.25 EUR
2021-07-14 Burkhardt, Dr. Lukas Board Buy None 181,357.60 EUR
2021-07-14 Siemssen, Dietmar Board Buy None 139,732.50 EUR

Peer Companies

Company Country Ticker View
ProstaLund AB Logo
Develops minimally invasive heat treatments and devices for BPH for global healthcare providers.
Sweden PLUN
Prostatype Genomics AB Logo
Provides a genetic test to assess prostate cancer aggressiveness and guide treatment choices.
Sweden PROGEN
Qiagen N.V. Logo
Provides 'Sample to Insight' solutions for molecular analysis in research and clinical healthcare.
Netherlands QIA
QLife Holding AB Logo
Develops an at-home IVD platform for biomarker and virus testing from blood samples.
Sweden QLIFE
IVD specialist in rapid antimicrobial susceptibility testing for critical infections like sepsis.
South Korea 317690
Raphas Co., Ltd. Logo
Develops dissolving microneedle patches for cosmetic, medical, and pharmaceutical applications.
South Korea 214260
Redsense Medical AB Logo
Develops FDA/CE-marked blood loss alarms for hemodialysis using fiber optic tech for EU/US markets.
Sweden REDS
Revenio Group Oyj Logo
Develops ophthalmic devices and software for early detection of significant eye diseases.
Finland REG1V
ROKIT HEALTHCARE Inc. Logo
Uses 3D bioprinting and AI for autologous organ regeneration to treat chronic conditions.
South Korea 376900
RootLoc Co., Ltd. Logo
Develops and sells orthopedic solutions like artificial joints and spinal implants globally.
South Korea 253610

Talk to a Data Expert

Have a question? We'll get back to you promptly.